Abstract
The use of doping substances in sport has a long history. One of the methods of combating unfair competition is testing the presence of those substances in athletes. For this purpose, appropriate measurement procedures are being developed, which allowed establishing a uniform, anti-doping system in sport. An important aspect of this system is the continuous development of new measurement procedures, allowing the detection of new substances and their metabolites. Such a system functions on a global level, and the Polish Anti-doping Laboratory cooperates on two aspects. On the one hand, it carries out tests in accordance with the requirements of commonly agreed procedures, thus ensuring the highest quality of results. On the other hand, it contributes significantly to the development of new procedures, thus supporting the entire anti-doping activities.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
WADA. The 2021 Prohibited List international standard. (2021) https://www.wada-ama.org/sites/default/files/resources/files/2021list_en.pdf. Accessed 22 Feb 2021.
WADA. World Anti-Doping Code, 2021. (2021) https://www.wada-ama.org/sites/default/files/resources/files/2021_wada_code.pdf. Accessed 22 Feb 2021.
WADA. International Standard for Laboratories 2021. (2021) https://www.wada-ama.org/sites/default/files/resources/files/isl_2021.pdf. Accessed 22 Feb 2021.
WADA. Technical document – TD2021DL v. 1.0. (2021) Decision limits for the confirmatory quantification of exogenous threshold substances by chromatography-based analytical methods. https://www.wada-ama.org/sites/default/files/resources/files/td2021dl_final_eng_0.pdf. Accessed 16 May 2021.
WADA. Technical document – TD2019MRPL. (2019) Minimum required performance levels for detection and identification of non-threshold substances. https://www.wada-ama.org/sites/default/files/resources/files/td2019mrpl_eng.pdf. Accessed 22 Feb 2021.
WADA. Technical document – TD2015IDCR. (2015) Minimum criteria for chromatographic-mass spectrometric confirmation of the identity of analytes for doping control purposes. https://www.wada-ama.org/sites/default/files/resources/files/td2021idcr_final_eng_0.pdf. Accessed 16 May 2021.
WADA. Technical letters TL2021 v. 3.0 index. (2021) https://www.wada-ama.org/sites/default/files/resources/files/tl2021_index_v3.0_wada_technical_letter_index.pdf. Accessed 16 May 2021.
Chołbiński, P., Wicka, M., Kowalczyk, K., Jarek, A., Kaliszewski, P., Pokrywka, A., Bulska, E., & Kwiatkowska, D. (2014). Detection of β-methylphenethylamine, a novel doping substance, by means of UPLC/MS/MS. Analytical and Bioanalytical Chemistry, 406, 3681–3688.
Wójtowicz, M., Jarek, A., Chajewska, K., Turek-Lepa, E., & Kwiatkowska, D. (2015). Determination of designer doping agent – 2-Ethylamino-1-phenylbutane – In dietary supplements and excretion study following single oral supplement dose. Journal of Pharmaceutical and Biomedical Analysis, 115, 523–533.
Kwiatkowska, D., Wójtowicz, M., Jarek, A., Goebel, C., Chajewska, K., Turek-Lepa, E., Pokrywka, A., & Kazlauskas, R. (2015). N,N-dimethyl-2-phenylpropan-1-amine – New designer agent found in athlete urine and nutritional supplement. Drug Testing and Analysis, 7(4), 331–335.
Wójtowicz, M., Jarek, A., Chajewska, K., & Kwiatkowska, D. (2016). N,N-dimethyl-2-phenylpropan-1-amine quantification in urine: Application to excretion study following single oral dietary supplement dose. Analytical and Bioanalytical Chemistry, 408(18), 5041–5047.
DrugBank. Amphetamine. https://www.drugbank.ca/drugs/DB00182. Access 22 Feb 2021.
DrugBank. Codeine. https://www.drugbank.ca/drugs/DB00318. Accessed 22 Feb 2021.
WADA. Technical letter TL-22. Ethylmorphine. (2021) https://www.wada-ama.org/sites/default/files/resources/files/tl22_ethylmorphine_v2.pdf. Accessed 16 May 2021.
DrugBank. Morphine. https://www.drugbank.ca/drugs/DB00295. Accessed 22 Feb 2021.
WADA. Technical letter TL-15. Hydromorphone. (2021) https://www.wada-ama.org/sites/default/files/resources/files/tl15_hydromorphone_eng_2021_1.pdf. Accessed 22 Feb 2021.
WADA. Technical letter TL-11. Oxymorphone. (2021) https://www.wada-ama.org/sites/default/files/resources/files/tl11_oxymorphone.pdf. Accessed 22 Feb 2021.
WADA. (2010). Additional information in regards to the reintroduction of pseudoephedrine to the 2010 Prohibited List. https://www.wada-ama.org/sites/default/files/resources/files/WADA_Additional_Info_Pseudoephedrine_2010_EN.pdf. Accessed 22 Feb 2021.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this entry
Cite this entry
Kwiatkowska, D., Bulska, E. (2022). Detection of Psychoactive Substances Used in Doping: Screening and Confirmation Procedures. In: Buszewski, B., Baranowska, I. (eds) Handbook of Bioanalytics. Springer, Cham. https://doi.org/10.1007/978-3-030-95660-8_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-95660-8_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-95659-2
Online ISBN: 978-3-030-95660-8
eBook Packages: Chemistry and Materials ScienceReference Module Physical and Materials ScienceReference Module Chemistry, Materials and Physics